Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.

F. Moreira,M. Grieb,B. Lutz
DOI: https://doi.org/10.1016/j.beem.2008.09.003
2009-02-01
Abstract:
What problem does this paper attempt to address?